Logo

IDT Acquires Belgian RNA-TEC to Bolster RNAi Play, Nab European Foothold

Sep 19, 2006
NEW YORK (GenomeWeb News) - Integrated DNA Technologies said today that it acquired a Belgian company specializing in RNA field to bolster its own offerings in the field and attain a foothold in Europe.
 
The RNA-TEC acquisition is aimed at broadening IDT’s capabilities in the large-scale RNA synthesis and purification space, especially with increased demand for scale-up of IDT’s Dicer-Substrate RNAi compounds for large screens and animal studies.
 
With RNA-TEC, a spin-off company of the University of Leuven, Belgium, IDT can also expand into the European market. IDT plans to update and expand the infrastructure at RNA-TEC’s headquarters.
 
Terms of the deal were not disclosed.

Filed under

Gene Editing, Gene Silencing, & CRISPR
RNAi
Breaking News
The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.